China’s BeiGene raises $903m from Hong Kong IPO

BeiGene has become the latest Chinese biotech to list on the Hong Kong stock exchange, raising $903m, near the top of its target range. The company – which has just started pivotal trials for its lead ... ( read original story ...)

Sinochem energy unit files for $2bn Hong Kong IPO

according to its filing for the IPO to the Hong Kong exchange. Its other businesses includes a number of assets including refining and logistics for crude oil and petrochemical products. Morgan Stanle... ( read original story ...)

Banking on regional development

In recent years, Hong Kong’s banking industry has focused on business expansion in the Guangdong-Hong Kong-Macao Bay Area as well as fintech innovation. Bank of China (Hong Kong) (BOCHK) implements th... ( read original story ...)